JENNIFER L GOOD

CIK 1229245 · President & CEO · last filed 2026-02-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.72M

Companies

4

Total Filings

43

Lifetime Open-Market Net

-$4.45M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TRVI President & CEO 218,576 $14.21 $3.11M -$195.5K 19 2026-02-20
RYTM Director 7,000 $88.38 $618.7K -$4.27M 12 2025-06-26
JUNIPER PHARMACEUTICALS INC (JNP) Delisted Director 0 $0 2 2018-08-15
PENWEST PHARMACEUTICALS CO (PPCO) Delisted President & CEO 18,034 $16.1K 10 2010-09-22

Recent Filings · Page 2 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-09-05 TRVI Mixed -$91.4K EDGAR
2024-08-28 RYTM Mixed -$455.2K EDGAR
2024-06-25 RYTM Exer (M) +3,000 $0 EDGAR
2024-06-20 RYTM Grant (A) $0 EDGAR
2024-05-22 TRVI Mixed -$16.7K EDGAR
2024-05-14 TRVI Mixed -$3.3K EDGAR
2024-02-16 TRVI Grant (A) $0 EDGAR
2023-06-23 RYTM Grant (A) $0 EDGAR
2023-02-16 TRVI Grant (A) $0 EDGAR
2022-09-19 TRVI Grant (A) $0 EDGAR
Showing 1120 of 43
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.